Cooper Shares Outstanding 2006-2018 | COO

Cooper shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Cooper shares outstanding for the quarter ending July 31, 2018 were 0.050B, a 0.2% increase year-over-year.
  • Cooper 2017 shares outstanding were 0.05B, a 1.22% increase from 2016.
  • Cooper 2016 shares outstanding were 0.049B, a 0.41% decline from 2015.
  • Cooper 2015 shares outstanding were 0.049B, a 0.49% increase from 2014.
Cooper Annual Shares Outstanding
(Millions of Shares)
2017 50
2016 49
2015 49
2014 49
2013 50
2012 49
2011 48
2010 47
2009 45
2008 45
2007 45
2006 48
2005 46
Cooper Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 50
Q2 2018 50
Q1 2018 49
Q4 2017 50
Q3 2017 50
Q2 2017 50
Q1 2017 49
Q4 2016 49
Q3 2016 49
Q2 2016 49
Q1 2016 49
Q4 2015 49
Q3 2015 49
Q2 2015 49
Q1 2015 49
Q4 2014 49
Q3 2014 49
Q2 2014 49
Q1 2014 49
Q4 2013 50
Q3 2013 50
Q2 2013 49
Q1 2013 50
Q4 2012 49
Q3 2012 49
Q2 2012 49
Q1 2012 49
Q4 2011 48
Q3 2011 49
Q2 2011 48
Q1 2011 47
Q4 2010 47
Q3 2010 46
Q2 2010 46
Q1 2010 46
Q4 2009 45
Q3 2009 46
Q2 2009 46
Q1 2009 45
Q4 2008 45
Q3 2008 47
Q2 2008 48
Q1 2008 45
Q4 2007 45
Q3 2007 48
Q2 2007 45
Q1 2007 45
Q4 2006 48
Q3 2006 47
Q2 2006 48
Q1 2006 48
Q4 2005 46
Q3 2005 48
Q2 2005 48
Q1 2005 39
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.024B $2.139B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.839B 22.43
McKesson (MCK) United States $24.205B 9.25
AmerisourceBergen (ABC) United States $19.202B 13.70
Align Technology (ALGN) United States $18.029B 46.00
Laboratory Of America Holdings (LH) United States $16.578B 15.00
Cardinal Health (CAH) United States $16.524B 11.09
Henry Schein (HSIC) United States $13.120B 21.57
DENTSPLY SIRONA (XRAY) United States $8.279B 16.53
West Pharmaceutical Services (WST) United States $8.159B 40.49
Merit Medical Systems (MMSI) United States $3.360B 39.79
Patterson (PDCO) United States $2.427B 17.06
CONMED (CNMD) United States $1.929B 32.05
STAAR Surgical (STAA) United States $1.784B 183.77
Atrion (ATRI) United States $1.343B 38.40
Antares Pharma (ATRS) United States $0.532B 0.00
Invacare (IVC) United States $0.189B 0.00
Lifevantage (LFVN) United States $0.161B 22.84
Endologix (ELGX) United States $0.106B 0.00
Pro-Dex (PDEX) United States $0.061B 27.17
Aceto (ACET) United States $0.055B 0.00
Biolase (BIOL) United States $0.027B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.019B 0.00